COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
5.21
-0.04 (-0.67%)
At close: Sep 12, 2025, 4:00 PM EDT
5.20
0.00 (-0.10%)
After-hours: Sep 12, 2025, 4:00 PM EDT
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $500.81 million as of September 12, 2025. Its market cap has decreased by -8.46% in one year.
Market Cap
500.81M
Enterprise Value
314.70M
1-Year Change
-8.46%
Ranking
Category
Stock Price
$5.21
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $500.81M, a decrease of -11.92%. That is a compound annual growth rate of -2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 502.73M | 94.38% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
| Sep 18, 2020 | 568.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |